Publication dates

1-10 of about 200 reports for Recombinant Protein

Purchase Reports From Reputable Market Research Publishers

China Recombinant Protein Drug Industry Report, 2014-2017

China Recombinant Protein Drug Industry Report, 2014-2017

  • $ 2 500
  • Industry report
  • November 2014
  • by Research In China

... China recombinant protein drug industry report, 2014-2017 the chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability ...

2013 Sales of Recombinant Therapeutic Antibodies & Proteins

2013 Sales of Recombinant Therapeutic Antibodies & Proteins

  • $ 66
  • Industry report
  • March 2014
  • by La Merie Publishing

... Business intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2013. Sales data were obtained from company publications and refer ...

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018

  • $ 4 650
  • Industry report
  • November 2013
  • by MarketsandMarkets

... Glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte colony-stimulating factor (g ...

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type, Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type, Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • November 2014
  • by MarketsandMarkets

... In products and technologies, and levels of output in order to remain successful. Single use bioreactor market by product type (recombinant proteins, monoclonal antibodies), cell type, technology (stirred ...

Biopharmaceutical and Vaccine Production Markets

Biopharmaceutical and Vaccine Production Markets

  • $ 3 995
  • Industry report
  • August 2014
  • by Kalorama Information

... Regulation of the market- company profilesthe report contains production segmentations for the mammalian cell, microbial cell, monoclonal antibody, other recombinant protein, vaccine ...

Life Science Tools and Reagents: Global Markets

Life Science Tools and Reagents: Global Markets

  • $ 6 650
  • Industry report
  • January 2014
  • by BCC Research

... Proteomics-related products and services (protein expression, purification and identification market); recombinant proteins market and in vitro assay development; antibodies as a research tool; cell biology ...

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

... The bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and in manufacturing of recombinant ...

Active Pharmaceutical Ingredients Global Market  - Forecast To 2020

Active Pharmaceutical Ingredients Global Market - Forecast To 2020

  • $ 4 500
  • Industry report
  • November 2014
  • by IQ4I Research & Consultancy Pvt. Ltd

... Pharmaceutical ingredient). Biotech api is further segmented into mammalian cell culture, monoclonal antibodies, recombinant proteins, vaccines, insulin analog, growth hormones and interferons. Mammalian cell ...

Toleranzia AB - Product Pipeline Review - 2014

Toleranzia AB - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

... Toleranzia ab - drug profiles 10recombinant protein for allergy 10product description 10mechanism of action 10r&d progress 10recombinant protein for autoimmune orphan indications 11 ...

MarketVIEW: RSV vaccines

MarketVIEW: RSV vaccines

  • $ 4 495
  • Industry report
  • May 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

... Including live-attenuated viruses and/or recombinant proteins, the most advanced of which is from us biotech novavax who have completed phase i trials with a vlp recombinant rsv-f fusion protein vaccine. ...

About 300 reports for Recombinant Protein

Download Unlimited Documents from Trusted Public Sources

Genomics market shares in China Forecast

  • January 2013
    19 pages
  • Genomics  

    Biotechnology  

  • China  

View report >

16 Companies for Recombinant Protein

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Eli Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.